PharmaBoardroom

Interview with Christian Bechon, Chairman & CEO, LFB

In the wake of the most recent CSIS meeting, LFB and Sanofi-Aventis announced the intention to collaborate in bioproduction. What are the terms to…

Interview with Claudio Santos, MD, MBA, General Manager, Shire…

We asked Mr. Santos regarding his recommendations to help the government innovate, compete, and grow in the pharmaceutical industry here in Brazil on…

Interview with Ralf Göddertz, General Manager of Germany,…

DAIICHI SANKYO in Germany, Austria and Switzerland DAIICHI SANKYO wants to be a Global Pharma Innovator with Germany at the center of this process…

Interview with Maurice Chagnaud, President, Teva France

We have had the chance to interview a number of Teva’s subsidiaries in Europe, and witnessed how each of them has dealt with the strong…

Interview with Emmanuel de Rivoire, Country Manager, Nycomed…

Nycomed lost an important patent with Pantoprazole in the middle of 2009, which has undoubtedly warranted some restructuring. What has been the impact…

Interview with Marisa Sanvito, Senior Director, Quintiles Brazil

Many international CROs entered Brazil in the past few years, whereas Quintiles made its first move in Brazil in 1996. What was the strategic decision…

Interview with Rubens Lima, General Manager, Ipsen Brazil

In a past interview, you said that Ipsen is different than the “Big Pharmas” who have entered Brazil by acquisition. You’ve taken a…

Interview with Mohamed Chaoui, General Manager, UCB Phrama France

Historically, UCB Pharma had a much more ‘traditional’ approach to the industry with a broader scope of operations. Recently, the company…

Interview with María Cristina Álvarez, President, Novartis De…

Being an industry giant with operations in over one hundred counties worldwide, what is the role and significance of Colombia for Novartis global? As…